Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000518054 | SCV000615163 | benign | not specified | 2017-05-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000549702 | SCV000645236 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848900 | SCV002105133 | likely benign | Hereditary spastic paraplegia | 2017-05-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420300 | SCV002727050 | likely benign | Inborn genetic diseases | 2020-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003233669 | SCV003931519 | likely benign | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233670 | SCV003931520 | likely benign | Amyotrophic lateral sclerosis type 4 | 2023-02-08 | criteria provided, single submitter | clinical testing |